Tag: BPH

Butterfly Medical Secures $21 Million in Upsized Series C Funding to Advance Minimally Invasive BPH Treatment

Strategic Investment Fuels FDA Regulatory Path and Global Commercialization; Company to Showcase Technology at AUA 2026 BOSTON and YOKNEAM, Israel, May 14, 2026 /PRNewswire/ — Butterfly Medical, developer of a proprietary non-surgical solution for BPH (benign prostatic hyperplasia), today announced the successful completion of its Series C funding round, raising $21 million. The strong […]

Merit Medical (MMSI)’s Embosphere Microspheres Receive FDA 513(F)(2) (De Novo) Classification For Prostatic Artery Embolization Indication

SOUTH JORDAN, Utah, June 22, 2017 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology and endoscopy, today announced that it has received 513(f)(2) (de novo) classification from the FDA to […]